{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:43:43Z","timestamp":1785293023845,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s11845-022-03173-w","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T20:37:22Z","timestamp":1664224642000},"page":"2015-2022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Assessment of serum neopterin and calprotectin as biomarkers for subclinical inflammation in patients with familial Mediterranean fever"],"prefix":"10.1007","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8295-9770","authenticated-orcid":false,"given":"Dilek","family":"Tezcan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8564-1824","authenticated-orcid":false,"given":"Duygu Eryavuz","family":"Onmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2956-5681","authenticated-orcid":false,"given":"Abdullah","family":"Sivrikaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6417-7310","authenticated-orcid":false,"given":"Selda","family":"Hakbilen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9524-6115","authenticated-orcid":false,"given":"Muslu Kaz\u0131m","family":"K\u00f6rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6085-9939","authenticated-orcid":false,"given":"Semral","family":"G\u00fclcemal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5076-1500","authenticated-orcid":false,"given":"Sema","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"issue":"8","key":"3173_CR1","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s10067-017-3715-5","volume":"36","author":"M Alghamdi","year":"2017","unstructured":"Alghamdi M (2017) Familial Mediterranean fever, review of the literature. Clin Rheumatol 36(8):1707\u20131713","journal-title":"Clin Rheumatol"},{"key":"3173_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/ped.15052","author":"V G\u00fcng\u00f6rer","year":"2021","unstructured":"G\u00fcng\u00f6rer V, Yorulmaz A, Arslan \u015e (2021) The clinical effect of gene mutations in familial Mediterranean fever Disease. Pediatr Int. https:\/\/doi.org\/10.1111\/ped.15052","journal-title":"Pediatr Int"},{"issue":"2","key":"3173_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/eji.201746947","volume":"48","author":"R Heilig","year":"2018","unstructured":"Heilig R, Broz P (2018) Function and mechanism of the pyrin inflammasome. Eur J Immunol 48(2):230\u2013238. https:\/\/doi.org\/10.1002\/eji.201746947","journal-title":"Eur J Immunol"},{"issue":"SI-2","key":"3173_CR4","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3906\/sag-2008-11","volume":"50","author":"A Tufan","year":"2020","unstructured":"Tufan A, Lachmann HJ (2020) Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review. Turk J Med Sci 50(SI-2):1591\u20131610. https:\/\/doi.org\/10.3906\/sag-2008-11","journal-title":"Turk J Med Sci"},{"key":"3173_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.mgene.2018.06.010","volume":"17","author":"M Zaki","year":"2018","unstructured":"Zaki M, El-Bassyouni HT, Reyad H et al (2018) Assessment of physical growth, some oxidative stress biomarkers and vitamin D status in children with familial Mediterranean fever. Meta Gene 17:212\u2013215","journal-title":"Meta Gene"},{"issue":"6","key":"3173_CR6","first-page":"45","volume":"84","author":"ZT Dzhndoyan","year":"2012","unstructured":"Dzhndoyan ZT (2012) Serum levels of myeloid-related protein MRP 8\/14 (calprotectin) in Armenian patients with familial Mediterranean fever. Ter Arkh 84(6):45\u201348","journal-title":"Ter Arkh"},{"issue":"6","key":"3173_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5114\/reum.2016.64907","volume":"54","author":"M Kope\u0107-M\u0119drek","year":"2016","unstructured":"Kope\u0107-M\u0119drek M, Widuchowska M, Kucharz EJ (2016) Calprotectin in rheumatic diseases: a review. Reumatologia 54(6):306\u2013309. https:\/\/doi.org\/10.5114\/reum.2016.64907","journal-title":"Reumatologia"},{"issue":"7","key":"3173_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/antiox7070080","volume":"7","author":"SP Gieseg","year":"2018","unstructured":"Gieseg SP, Baxter-Parker G, Lindsay A (2018) Neopterin, inflammation, and oxidative stress: what could we be missing? Antioxidants (Basel, Switzerland) 7(7):80. https:\/\/doi.org\/10.3390\/antiox7070080","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"11","key":"3173_CR9","volume":"12","author":"L Jafri","year":"2020","unstructured":"Jafri L, Siddiqui A, Sidddique S et al (2020) Clinical spectrum in a cohort of patients with high fecal calprotectin levels. Cureus 12(11):e11314","journal-title":"Cureus"},{"issue":"3","key":"3173_CR10","first-page":"219","volume":"16","author":"AF Khalil","year":"2021","unstructured":"Khalil AF, Helmy EM, Massoud MN et al (2021) Does faecal calprotectin differentiate between inflammatory bowel disease colitis and non-inflammatory bowel disease colitides? Prz Gastroenterol 16(3):219\u2013223","journal-title":"Prz Gastroenterol"},{"key":"3173_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106948","volume":"88","author":"Y Ma","year":"2020","unstructured":"Ma Y, Fan D, Xu S et al (2020) Calprotectin in spondyloarthritis: a systematic review and meta-analysis. Int Immunopharmacol 88:106948. https:\/\/doi.org\/10.1016\/j.intimp.2020.106948","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"3173_CR12","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1177\/1535370216681551","volume":"242","author":"F Ometto","year":"2017","unstructured":"Ometto F, Friso L, Astorri D et al (2017) Calprotectin in rheumatic diseases. Exp Biol Med (Maywood) 242(8):859\u2013873","journal-title":"Exp Biol Med (Maywood)"},{"issue":"6","key":"3173_CR13","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jbspin.2019.01.003","volume":"86","author":"X Romand","year":"2019","unstructured":"Romand X, Bernardy C, Nguyen MVC et al (2019) Systemic calprotectin and chronic inflammatory rheumatic diseases. Joint Bone Spine 86(6):691\u2013698","journal-title":"Joint Bone Spine"},{"issue":"10","key":"3173_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00011-018-1173-4","volume":"67","author":"F Shabani","year":"2018","unstructured":"Shabani F, Farasat A, Mahdavi M et al (2018) Calprotectin (S100A8\/S100A9): a key protein between inflammation and cancer. Inflamm Res 67(10):801\u2013812","journal-title":"Inflamm Res"},{"issue":"1","key":"3173_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00011-021-01512-8","volume":"71","author":"F Cherubini","year":"2022","unstructured":"Cherubini F, Cristiano A, Valentini A et al (2022) Correction to: circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study. Inflamm Res 71(1):1\u20138","journal-title":"Inflamm Res"},{"issue":"1","key":"3173_CR16","first-page":"109","volume":"33","author":"A Mariani","year":"2015","unstructured":"Mariani A, Marsili M, Nozzi M et al (2015) Serum calprotectin: review of its usefulness and validity in paediatric rheumatic diseases. Clin Exp Rheumatol 33(1):109\u2013114","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"3173_CR17","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1080\/1744666X.2021.1945441","volume":"17","author":"S Rosina","year":"2021","unstructured":"Rosina S, Natoli V, Santaniello S et al (2021) Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritis. Expert Rev Clin Immunol 17(8):853\u2013870","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"3173_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s13075-014-0413-4","volume":"19;16","author":"MC Turina","year":"2014","unstructured":"Turina MC, Yeremenko N, Paramarta JE et al (2014) Calprotectin (S100A8\/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis. Arthritis Res Ther 19;16(4):413","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3173_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13075-020-02190-3","volume":"6;22","author":"M Jarlborg","year":"2020","unstructured":"Jarlborg M, Courvoisier DS, Lamacchia C et al (2020) Physicians of the Swiss Clinical Quality Management (SCQM) registry. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Res Ther 6;22(1):105","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"3173_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ajg.2021.05.020","volume":"22","author":"C Ercalik","year":"2021","unstructured":"Ercalik C, Baskaya MC, Ozdem S et al (2021) Investigation of asymptomatic intestinal inflammation in ankylosing spondylitis by fecal calprotectin. Arab J Gastroenterol 22(4):272\u2013277","journal-title":"Arab J Gastroenterol"},{"issue":"7","key":"3173_CR21","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/acr.22795","volume":"68","author":"J Inciarte-Mundo","year":"2016","unstructured":"Inciarte-Mundo J, Victoria Hern\u00e1ndez M, Ruiz-Esquide V et al (2016) Serum calprotectin versus acute-phase reactants in the discrimination of inflammatory disease activity in rheumatoid arthritis patients receiving tumor necrosis factor inhibitors. Arthritis Care Res (Hoboken) 68(7):899\u2013906","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"3173_CR22","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","volume":"70","author":"A Jukic","year":"2021","unstructured":"Jukic A, Bakiri L, Wagner EF et al (2021) Calprotectin: from biomarker to biological function. Gut 70(10):1978\u20131988","journal-title":"Gut"},{"issue":"5","key":"3173_CR23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1080\/14397595.2018.1519103","volume":"29","author":"H Hu","year":"2019","unstructured":"Hu H, Du F, Zhang S et al (2019) Serum calprotectin correlates with risk and disease severity of ankylosing spondylitis and its change during first month might predict favorable response to treatment. Mod Rheumatol 29(5):836\u2013842","journal-title":"Mod Rheumatol"},{"issue":"2","key":"3173_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3109\/00365513.2014.984319","volume":"75","author":"P Oktayoglu","year":"2015","unstructured":"Oktayoglu P, Mete N, Caglayan M et al (2015) Elevated serum levels of calprotectin (MRP8\/MRP14) in patients with Beh\u00e7et\u2019s disease and its association with disease activity and quality of life. Scand J Clin Lab Invest 75(2):106\u2013112","journal-title":"Scand J Clin Lab Invest"},{"issue":"6","key":"3173_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.autrev.2015.01.018","volume":"14","author":"I Marie","year":"2015","unstructured":"Marie I, Leroi AM, Menard JF et al (2015) Fecal calprotectin in systemic sclerosis and review of the literature. Autoimmun Rev 14(6):547\u2013554","journal-title":"Autoimmun Rev"},{"issue":"10","key":"3173_CR26","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.3346\/jkms.2020.35.e63","volume":"16;35","author":"G Asan","year":"2020","unstructured":"Asan G, Derin ME, Do\u011fan HO et al (2020) Can calprotectin show subclinical inflammation in familial Mediterranean fever patients? J Korean Med Sci 16;35(10):e63","journal-title":"J Korean Med Sci"},{"issue":"11","key":"3173_CR27","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/ped.13995","volume":"61","author":"F Demirba\u015f","year":"2019","unstructured":"Demirba\u015f F, \u00c7altepe G, Comba A et al (2019) Fecal calprotectin in children with familial Mediterranean fever in the attack-free period. Pediatr Int 61(11):1140\u20131145","journal-title":"Pediatr Int"},{"issue":"10","key":"3173_CR28","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1111\/1756-185X.13396","volume":"21","author":"OA Gucenmez","year":"2018","unstructured":"Gucenmez OA, Kume T, Makay B et al (2018) Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever. Int J Rheum Dis 21(10):1844\u20131848","journal-title":"Int J Rheum Dis"},{"issue":"8","key":"3173_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256072","volume":"16","author":"G Baxter-Parker","year":"2021","unstructured":"Baxter-Parker G, Roffe L, Moltchanova E et al (2021) Urinary neopterin and total neopterin measurements allow monitoring of oxidative stress and inflammation levels of knee and hip arthroplasty patients. PLoS ONE 16(8):e0256072","journal-title":"PLoS ONE"},{"issue":"1","key":"3173_CR30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.5604\/01.3001.0010.3851","volume":"71","author":"\u0141 Michalak","year":"2017","unstructured":"Michalak \u0141, Bulska M, Strz\u0105ba\u0142a K et al (2017) Neopterin as a marker of cellular immunological response. Postepy Hig Med Dosw (Online) 71(1):727\u2013736","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"4","key":"3173_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13443","volume":"33","author":"F Akyurek","year":"2020","unstructured":"Akyurek F, Tuncez Akyurek F (2020) Investigation of pregnancy associated plasma protein-A and neopterin levels in Beh\u00e7et\u2019s patients. Dermatol Ther 33(4):e13443","journal-title":"Dermatol Ther"},{"issue":"3","key":"3173_CR32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/cei.13404","volume":"199","author":"QL Peng","year":"2020","unstructured":"Peng QL, Zhang YM, Liang L et al (2020) A high level of serum neopterin is associated with rapidly progressive interstitial lung disease and reduced survival in dermatomyositis. Clin Exp Immunol 199(3):314\u2013325","journal-title":"Clin Exp Immunol"},{"key":"3173_CR33","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.2147\/DMSO.S315986","volume":"14","author":"RH Wan","year":"2021","unstructured":"Wan RH, Yuan Y, Hao W et al (2021) Relationship between serum neopterin level and peripheral arterial plaque in patients with type 2 diabetes. Diabetes Metab Syndr Obes 14:2871\u20132878","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"-","key":"3173_CR34","first-page":"1759720X1983232","volume":"11","author":"F Yavuz","year":"2019","unstructured":"Yavuz F, Kesikburun B, \u00d6zt\u00fcrk \u00d6 et al (2019) Serum chitotriosidase and neopterin levels in patients with ankylosing spondylitis. Ther Adv Musculoskelet Dis 11:1759720X19832321","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"13","key":"3173_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.21037\/atm.2017.06.29","volume":"5","author":"B Melichar","year":"2017","unstructured":"Melichar B, Spisarov\u00e1 M, Bartou\u0161kov\u00e1 M et al (2017) Neopterin as a biomarker of immune response in cancer patients. Ann Transl Med 5(13):280","journal-title":"Ann Transl Med"},{"key":"3173_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.709893","volume":"11","author":"M Chauvin","year":"2021","unstructured":"Chauvin M, Larsen M, Quirant B et al (2021) Elevated neopterin levels predict fatal outcome in SARS-CoV-2-infected patients. Front Cell Infect Microbiol 11:709893","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"3173_CR37","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.intimp.2013.08.022","volume":"17","author":"D Arshadi","year":"2013","unstructured":"Arshadi D, Nikbin B, Shakiba Y et al (2013) Plasma level of neopterin as a marker of disease activity in treated rheumatoid arthritis patients: association with gender, disease activity and anti-CCP antibody. Int Immunopharmacol 17(3):763\u2013767","journal-title":"Int Immunopharmacol"},{"key":"3173_CR38","doi-asserted-by":"publisher","first-page":"5536360","DOI":"10.1155\/2021\/5536360","volume":"2021","author":"S Shi","year":"2021","unstructured":"Shi S, Chen L, Gui X et al (2021) Association of red blood cell distribution width levels with connective tissue disease-associated interstitial lung disease (CTD-ILD). Dis Markers 2021:5536360","journal-title":"Dis Markers"},{"key":"3173_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.12659\/MSM.892289","volume":"21","author":"S \u00d6zer","year":"2015","unstructured":"\u00d6zer S, Y\u0131lmaz R, S\u00f6nmezg\u00f6z E et al (2015) Simple markers for subclinical inflammation in patients with familial Mediterranean fever. Med Sci Monit 21:298\u2013303","journal-title":"Med Sci Monit"},{"issue":"4","key":"3173_CR40","doi-asserted-by":"publisher","first-page":"298","DOI":"10.2174\/1573397116666200312142709","volume":"16","author":"H Marzouk","year":"2020","unstructured":"Marzouk H, Mostafa N, Khalifa I et al (2020) Red cell distribution width (RDW) as a marker of subclinical inflammation in children with familial Mediterranean fever. Curr Rheumatol Rev 16(4):298\u2013303","journal-title":"Curr Rheumatol Rev"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-03173-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-022-03173-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-03173-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:06:25Z","timestamp":1744157185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-022-03173-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["3173"],"URL":"https:\/\/doi.org\/10.1007\/s11845-022-03173-w","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"assertion":[{"value":"12 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The paper has not been presented, published, or submitted for publication elsewhere.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was designed as a prospective study and was approved by the ethics committee of the Sel\u00e7uk University Faculty of Medicine Hospital with the decision dated 30.12.2020 and numbered 2020\/573.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants were written informed according to the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}